期刊文献+

P-糖蛋白在大鼠癫痫持续状态表达的动态变化及其意义 被引量:1

Significance and dynamic expression of P-glycoprotein in status epilepticus rats
下载PDF
导出
摘要 目的:研究戊四氮诱导的大鼠癫痫持续状态模型(status epilepticus,SE)中,P-糖蛋白(P-glycoprotein,P-gp)在72 h内表达的动态变化,为下一步抑制P-gp的表达选定最佳检测时间点。方法:用免疫组化、RT-q PCR和Western blot检测建模后不同时点(0、3、6、12、24、48、72 h)海马组织中P-gp表达的变化情况。结果:免疫组化结果:海马组织中P-gp蛋白在SE 24 h组的平均光密度值为0.325 1±0.008 2,比对照组增加(P<0.05),SE 48 h组的平均光密度值为0.396 3±0.016 8,显著高于对照组(P<0.01);RT-q PCR结果:MDR1a基因在SE 24 h组比对照组增加(P<0.05),SE 48 h组显著高于对照组(P<0.01);Western blot结果:P-gp蛋白在SE 48 h组比对照组增加(P<0.05)。这些结果显示,SE模型中海马组织内P-gp表达在24 h后开始升高,并在48 h达高峰。结论:SE后48 h P-gp的表达达最高峰,此时可能为减少SE后产生耐药的最佳检测时间。 Objective To investigate the dynamic expression of the drug resistance protein P-glycoprotein (P-gp) within 72 hours in the pentylenetetrazol (PTZ)-induced status epilepticus (SE) model, and to identify the optimal detection time to inhibit P-gp. Methods mRNA and protein expressions of P-gp in rats hippocampal tissue were detected by using immunohistochemistry , RT-qPCR and Western blot at different time points after modeling (0, 3, 6, 12, 24, 48, 72 h). Results The mean density of P-gp protein in the hippocampus of status epilepticus model was 0.325 1 ± 0.008 2 at 24 h, and was 0.396 3 ± 0.016 8 at 48 h, which were consistently higher than those of the control group (P 〈 0.05, P 〈 0.01, respectively). Results of qRT-PCR showed that MDR1a expression was significantly upregulated at 24 h and at 48 h (P 〈 0.05, P 〈 0.01, respectively). Western blot assay revealed that P-gp protein was also significantly increased at 48 h after seizures (P 〈 0.05). Conclusions The upregulation of P-gp after SE peaked at 48 h, which maybe the optimal detection time to detect drug resistant after SE.
出处 《实用医学杂志》 CAS 北大核心 2014年第23期3735-3738,共4页 The Journal of Practical Medicine
基金 广州市科技计划项目(编号:2010YI-C891 11C32020697 2013J4100103) 广州市属高校科研计划项目(编号:2012D001 2012c128)
关键词 癫痫持续状态 P-糖蛋白 戊四氮 耐药蛋白 Status epilepticus P-glycoprotein Pentylenetetrazol Drug Resistance protein
  • 相关文献

参考文献12

  • 1Yoshida S, Sugawara T, Nishio T, et al. Personalized medicine for epilepsy based on the pharmacogenomic testing[J]. Brain Nerve, 2011,63(4) :295-299.
  • 2秦兵,廖卫平,臼井直敬,寺田清人,井上有史.癫痫:全球重点防治的神经精神疾病[J].实用医学杂志,2012,28(13):2109-2111. 被引量:44
  • 3Feldmann M, Asselin MC, LiuJ, et al. P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study[J]. Lancet Neurol, 2013,12(8):777-785.
  • 4Hussenet F, Boyet S, Nehlig A. Long-term metabolic effects of pentylenetetrazol-induced status epileptic us in the immature rat[J]. Neuroscience, 1995,67(2) :455-461.
  • 5Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure[J]. Electroencephalogr Clin Neurophysiol, 1972,32(3):281-294.
  • 6Borst P, Schinkel AH. P-glycoprotein ABCBl: a major player in drug handing by mammals[J].J Clin Invest, 2013,123 (10): 4131-4133.
  • 7Yu N, Di Q, Liu H, et al. Nuclear factor-kappaJ3 activity regulates brain expression of P-glycoprotein in the kainic acidinduced seizure rats[J]. Mediators Inflamm, 2011,2011: 670613.
  • 8LiuJY, Thorn M, Catarino CB, et al. Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy[J]. Brain, 2012,135(Pt 10) :3115-3133.
  • 9郝勇,吴洵昳,任惠民,丁玎,朱国行,于欢,洪震.地佐环平对边缘叶癫痫发作大鼠海马P-糖蛋白表达的影响[J].中华医学杂志,2007,87(23):1641-1645. 被引量:2
  • 10Lazarowski A, Czomyj L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions[J]. Drug Metablo Drug Interact, 2011, 26 ( I ) : 21-26.

二级参考文献8

共引文献44

同被引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部